John Baldoni is of MiNK Therapeutics, Inc.. Currently has a direct ownership of 41,193 shares of INKT, which is worth approximately $29,658. The most recent transaction as insider was on Sep 01, 2023, when has been sold 9,846 shares (Common Stock) at a price of $1.46 per share, resulting in proceeds of $14,375. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.2K
0% 3M change
0% 12M change
Total Value Held $29,658

John Baldoni Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2023
BUY
Grant, award, or other acquisition
$14,375 $1.46 p/Share
9,846 Added 19.29%
41,193 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
$14,375 $1.76 p/Share
8,168 Added 20.58%
31,528 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
$14,375 $2.09 p/Share
6,878 Added 22.75%
23,360 Common Stock
Dec 01 2022
BUY
Grant, award, or other acquisition
$14,375 $2.61 p/Share
5,508 Added 25.05%
16,482 Common Stock
Sep 15 2022
BUY
Grant, award, or other acquisition
$28,752 $2.62 p/Share
10,974 Added 50.0%
10,974 Common Stock
JB

John Baldoni

New York, NY

Track Institutional and Insider Activities on INKT

Follow MiNK Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

News

Receive news related to MiNK Therapeutics, Inc.

Track Activities on INKT